US regulator to curtail use of primate testing in drug trials
FDA decision aligns with Trump administration’s effort to lower pharma costs by eliminating lab monkey requirement
Related reading
US set to speed up approval for some generic drugs in blow to Big Pharma
Move is latest broadside by Trump administration against pharmaceuticals industry that fought to derail changes
Prices for lab monkeys surge on China biotech boom
More drugs entering middle or late-stage development drive up demand
US readies new pharmaceutical tariffs
Levies of 100% on certain medicines would implement threats Trump made last year
UK urges pharma companies to invest after reaching drug pricing deal with US
Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs
US to slash prices of obesity drugs offered on Trump website
White House’s landmark deal with Novo Nordisk and Eli Lilly will cut costs from at least $1,000 to about $350
EU trims exclusivity window for new drugs
Cheaper generics will be allowed on to market a year earlier to curb costs